Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
47,289,231
-
Share change
-
+1,075,449
-
Total reported value
-
$16,550,223
-
Put/Call ratio
-
21%
-
Price per share
-
$0.35
-
Number of holders
-
46
-
Value change
-
-$1,529,193
-
Number of buys
-
18
-
Number of sells
-
22
Institutional Holders of ALIGOS THERAPEUTICS INC - COM NEW (ALGS) as of Q2 2024
As of 30 Jun 2024,
ALIGOS THERAPEUTICS INC - COM NEW (ALGS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,289,231 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, EcoR1 Capital, LLC, Deep Track Capital, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Vivo Capital, LLC, HHLR ADVISORS, LTD., BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, and Versant Venture Management, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.